(MENAFN- GlobeNewsWire - Nasdaq) The North America Heart Pump Device market is projected to grow from USD 2.92 billion in 2024 to USD 8.1 billion by 2033, reflecting a CAGR of 12% between 2025-2033.

CorWave, a clinical-stage medical device company dedicated to the fight against heart failure, today announced the presentation of interim results from its FIH study evaluating its Left Ventricular ...

Primary endpoint successfully met, no device-related serious adverse events at 30 days Pulsatility preserved throughout the study with beat-to-beat valve opening Successful transplantation after 84 ...

PARIS, Sept. 9, 2025 /PRNewswire/ -- Okomera is pleased to announce that Silvère Lucquin will assume the role of Chief Executive Officer, effective 8 September 2025. Silvère succeeds Sidarth Radjou, ...

First-of-its-kind heart pump implanted in Australia, based on a breakthrough wave membrane technology. Unlike existing devices, CorWave's technology does not eliminate the effects of the native ...

"Cardiac Assist Devices Market Insights, Competitive Landscape, and Market Forecast - 2030"The Cardiac Assist Devices market, valued at $3B in 2023, is set to reach $6.23B by 2030 at a CAGR of 13.7%.

French medical device company CorWave has announced the world’s first implantation in a patient of its Left Ventricular Assist System (LVAS), the first heart pump ...

This screen grab from a CorWave marketing video shows the inside of the French company’s LVAD. [Image courtesy of CorWave] CorWave today announced the world’s first human implantation of its left ...